一站式综合服务

BD

放大字体  缩小字体 2021-10-18
  • 品牌名称:BD
  • 公司名称:BIOMETER
  • 官方主页:暂无
  • 所在地区:进口
品牌介绍

BD是世界上最大的生产和销售医疗设备,医疗系统和试剂的医疗技术公司之一,致力于提高全世界人类的健康水平。BD专注于改进药物治疗,提高传染性疾病诊断的质量和速度,推进新型药物和疫苗的研究与发现。BD公司具有强大的研发能力和世界上最棘手的多种疾病进行斗争。公司于1897年在纽约成立,总部位于美国新泽西州的富兰克林湖,在全球约50个国家拥有超过25000名雇员。公司的服务对象包括医疗机构,生命科学研究所,临床实验室,工业单位和普通大众。

BD医疗---下设医疗系统,糖尿病护理系统,眼科系统,制药系统四个部门。医疗系统的产品主要包括医用注射器, 静脉输液套管针,麻醉产品等。糖尿病护理系统的产品主要有胰岛素注射器、笔用针头及糖尿病护理产品。眼科系统主要提供眼科手术刀和配套产品及LASIK板层刀。制药系统生产供制药企业使用的预充式注射器。

BD生物科学---产品有流式细胞仪,单克隆抗体系列产品,生物科学研究试剂,细胞培养及实验室耗材和基因研究的分子生物学产品。

BD诊断---分为标本分析前处理系统和诊断系统。标本分析前处理系统包括真空采血系统,血沉标本采集及试验系统,尿液标本采集系统,末梢血常规和安全采样系统,动脉血气标本采集系统,标本采集废弃物收集系统 ,血袋产品等。诊断系统向市场提供成品和干粉培养基,手工双相培养瓶,全自动血培养系统,全自动、半自动细菌鉴定和药敏系统,全自动和手工分枝杆菌培养及药敏系统,荧光探针检测系统和以标本管理为核心的医疗误差控制系统。

BD在中国的发展

早在二十世纪初,BD的温度计、可重复使用的注射器等产品就通过国际红十字组织等进入中国,服务大众。

BD于1994年正式派员在中国注册建立代表机构,开展对华业务。次年8月BD投资2500万美元在中国苏州工业园区建立生产企业---苏州碧迪医疗器械有限公司。BD在中国的发展迅速,目前成立了--碧迪医疗器械(上海)有限公司,以上海为BD中国总部,北京、广州等十个办事处为核心的业务格局,带动辐射全国;员工800多人。

BD在将世界先进的医疗技术引入中国的同时更注重与医护人员和患者的交流,致力于改善整个社会的医疗环境,提高大众的医疗水平。

BD作为各国际组织(WHO、UNICEF)的合作伙伴积极参与支持中国的免疫接种、安全注射等活动,并在全国对医护人员开展了一系列安全注射的讲座。

BD还与护理学会、麻醉学会密切合作,举办了一系列的学习班,并多次邀请国内外知名教授、学者介绍国际先进的医疗技术如:联合麻醉无痛分娩技术、静脉输液新概念、临床实验室全面解决方案和疾病感染控制、流式细胞术学术研讨会等,赢得了医护界的一致好评。

BD此外还资助并协同美国HOPE基金会在中国开展了为期五年的中国糖尿病教育项目。

前景展望

BD是一百年质量与革新的领导者,BD将不断拓展在亚洲与中国的发展,并和中国的各级政府及医疗卫生组织合作将最新的医疗技术引入中国,服务于大众。
2017年BD宣布240亿美金收购巴德


BD is one of the largest medical technology companies in the world that produce and sell medical equipment, medical systems and reagents. It is committed to improving human health all over the world. BD focuses on improving drug treatment, improving the quality and speed of infectious disease diagnosis, and promoting the research and discovery of new drugs and vaccines. 

BD company has strong R & D capability to fight against many of the world's most intractable diseases. Founded in New York in 1897, the company is headquartered in Franklin Lake, New Jersey, with more than 25000 employees in about 50 countries around the world. The company's clients include medical institutions, life sciences research institutes, clinical laboratories, industrial units and the general public.

BD medical care - four departments, namely, the medical system, the diabetes care system, the ophthalmic system and the pharmaceutical system. The products of the medical system mainly include medical syringes, intravenous infusion trocar, anesthesia products, etc. The main products of the diabetes care system are insulin injectors, pen needles and diabetes care products. The ophthalmic system mainly provides ophthalmic scalpels, supporting products and LASIK lamellar scalpels. The pharmaceutical system produces pre filled syringes for pharmaceutical enterprises.
BD bioscience products include flow cytometry, monoclonal antibody series products, bioscience research reagents, cell culture and laboratory consumables and molecular biology products for gene research.

BD diagnosis is divided into sample analysis pre-processing system and diagnosis system. The pre-treatment system for sample analysis includes vacuum blood collection system, ESR sample collection and test system, urine sample collection system, peripheral blood routine and safety sampling system, arterial blood gas sample collection system, sample collection waste collection system, blood bag products, etc. The diagnostic system provides the market with finished product and dry powder culture medium, manual biphasic culture bottle, automatic blood culture system, automatic and semi-automatic bacterial identification and drug sensitivity system, automatic and manual mycobacterium culture and drug sensitivity system, fluorescent probe detection system and medical error control system with specimen management as the core.

Development of BD in China
As early as the early 20th century, BD's thermometers, reusable syringes and other products entered China through the International Red Cross to serve the public.
BD officially sent personnel to register and establish a representative office in China in 1994 to carry out business in China. In August of the next year, BD invested US $25 million to establish a manufacturing enterprise in Suzhou Industrial Park, China - Suzhou bidi medical device Co., Ltd. BD is developing rapidly in China. At present, bidi medical devices (Shanghai) Co., Ltd. has been established. With Shanghai as BD's China headquarters and ten offices in Beijing and Guangzhou as the core, BD's business pattern has driven and radiated throughout the country; More than 800 employees.

While introducing the world's advanced medical technology into China, BD pays more attention to the communication with medical staff and patients, and is committed to improving the medical environment of the whole society and improving the medical level of the public.

As a partner of various international organizations (who, UNICEF), BD actively participated in supporting China's immunization, safe injection and other activities, and held a series of lectures on safe injection for medical staff throughout the country.

BD also cooperated closely with the society of nursing and the society of Anesthesiology, held a series of study classes, and repeatedly invited well-known professors and scholars at home and abroad to introduce international advanced medical technologies, such as joint anesthesia painless delivery technology, new concepts of intravenous infusion, comprehensive solutions in clinical laboratories, disease infection control, academic seminars on flow cytometry, etc, It has won unanimous praise from the medical profession.

BD also funded and coordinated the HOPE foundation in China for a five year diabetes education program in China.

Prospect

BD is a 100 year leader in quality and innovation. BD will continue to expand its development in Asia and China, and cooperate with Chinese governments at all levels and medical and health organizations to introduce the latest medical technology into China and serve the public.
In 2017, BD announced the acquisition of Bard with us $24 billion

反对 0举报 0 收藏 0 评论 0
联系方式
其他推荐品牌